Fabrication and evaluation of novel quercetin-conjugated Fe(3)O(4)–β-cyclodextrin nanoparticles for potential use in epilepsy disorder

BACKGROUND: Despite the numerous pharmacological activities of quercetin, its biomedical application has been hampered, because of poor water solubility and low oral bioavailability. In the present study, we fabricated a novel form of quercetin-conjugated Fe(3)O(4)–β-cyclodextrin (βCD) nanoparticles...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashemian, Mona, Ghasemi-Kasman, Maryam, Ghasemi, Shahram, Akbari, Atefeh, Moalem-Banhangi, Monire, Zare, Leila, Ahmadian, Seyed Raheleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698168/
https://www.ncbi.nlm.nih.gov/pubmed/31496698
http://dx.doi.org/10.2147/IJN.S218317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698168/
https://www.ncbi.nlm.nih.gov/pubmed/31496698
http://dx.doi.org/10.2147/IJN.S218317

Ejemplares similares